Allied Market Research

2025

India Biosimilars And Follow-on Biologics Market

India Biosimilars and Follow-On Biologics Market, by Product (ERYTHROPOETIN, GRANULOCYTE-COLONY STIMULATING FACTOR, GROWTH HORMONE, ALFA INTERFERON, BETA INTERFERON, MONOCLONAL ANTIBODY, FOLLITROPIN, Others), by Application (BLOOD DISORDER, CANCER, CHRONIC AND AUTOIMMUNE DISEASE, GROWTH HORMONE DEFICIENCY, Others) and, by Manufacturing (IN-HOUSE MANUFACTURING, CONTRACT MANUFACTURING ORGANIZATION): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

  • Oct 2025

  • Pages: NA

  • Tables: NA

  • Charts: NA

Select an option
Cloud Access (30% Off) $3,690 $2,583
Business User License (30% Off) $5,820 $4,074
Enterprise License (30% Off) $9,870 $6,909
Library Membership (15% Off) $1,175 $999
Enquiry Now
Author's: | Roshan Deshmukh
Publish Date:
Enquire Before Buying Customization Request Speak with Analyst

Get Sample to Email

  India Biosimilars and Follow-On Biologics Market Report Highlights

Aspects Details
icon_5
By Product
  • ERYTHROPOETIN
  • GRANULOCYTE-COLONY STIMULATING FACTOR
  • GROWTH HORMONE
  • ALFA INTERFERON
  • BETA INTERFERON
  • MONOCLONAL ANTIBODY
  • FOLLITROPIN
  • Others
icon_6
By Application
  • BLOOD DISORDER
  • CANCER
  • CHRONIC AND AUTOIMMUNE DISEASE
  • GROWTH HORMONE DEFICIENCY
  • Others
icon_7
By Manufacturing
  • IN-HOUSE MANUFACTURING
  • CONTRACT MANUFACTURING ORGANIZATION
icon_8
Key Market Players

Intas Pharmaceuticals Ltd., Wockhardt Ltd., Cadila Healthcare Ltd., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Hetero Drugs Ltd., Biocon Ltd., Cipla Ltd., Reliance Life Sciences Pvt. Ltd., Nicholas Piramal India Ltd.

Loading Table Of Content...

*Terms and Conditions Apply

India Biosimilars and Follow-On Biologics Market

Global Opportunity Analysis and Industry Forecast, 2023-2032

help@alliedmarketresearch.com